投资者关系活动记录表 编号：2025-019 | | 特定对象调研 ☑ | □分析师会议 | | --- | --- | --- | | 投资者关系活 动类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | □其他（请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 长江证券、长盛基金 | | | 时间 | 2025 年 12 月 30 | 日 | | 地点 | 博苑股份会议室 | | | 上市公司接待 | 1、董事会秘书：张山岗 | | | 人员姓名 | 2、财务总监：孙腾 | | | | 3、证券事务代表：杨艳丽 | | | | | 1、贵公司碘化物产品产能及相关品类？ | | | | 答：公司碘化物产品现有产能 吨/年，试生产阶段项 4,100 | | | 目 4,000 | 吨/年。其中，无机碘化物主要包括碘化钾、碘酸钾、 | | | | 碘化钠、氢碘酸、碘化亚铜等；有机碘化物产品主要有三甲基 | | | 碘硅烷、碘甲烷等。 | | | 投资者关系活 | | 2、碘及碘衍生物的主要应用与资源分布？ | | 动主要内容介 | | 答：碘 ...

Core Viewpoint - The company, Boyuan Co., Ltd. (301617), is positioned as a leader in the fine chemical sector, successfully navigating the transition from "scale expansion" to "green high-quality development" in the context of the global "dual carbon" strategy [1] Group 1: Circular Economy and Business Model - Boyuan Co., Ltd. has established a circular economy business model centered on the recovery and utilization of iodine and precious metals, differentiating itself from traditional chemical enterprises [2] - This model allows the company to procure iodine and precious metal-containing waste from upstream enterprises, effectively addressing waste disposal challenges while reducing raw material dependency and production costs [2] - The circular economy approach not only mitigates risks associated with imported raw material price fluctuations but also enhances customer trust, leading to long-term cooperation agreements [2] Group 2: Integrated Service Capability - The company has developed a comprehensive service capability that spans from basic chemical raw material supply to hazardous waste resource utilization and product processing, fostering mutually beneficial strategic partnerships with major clients [3] - Boyuan Co., Ltd.'s iodine resource utilization business is recognized for its advanced recycling processes and large-scale processing capabilities, placing it in a leading position within the industry [3] Group 3: Technological Innovation and Product Development - The company emphasizes technological innovation as a key driver of growth, increasing R&D investment and accelerating the commercialization of research outcomes [5] - Boyuan Co., Ltd. is focusing on high-end and emerging fields such as new materials and new energy, aiming to enhance product structure and extend the industrial chain [5] - The company actively participates in the establishment of industry standards, having contributed to the formulation of 3 industry standards and 11 group standards, thereby enhancing its professional influence [4] Group 4: Strategic Growth and Market Positioning - Boyuan Co., Ltd. maintains a cautious yet open approach to mergers and acquisitions, considering opportunities that align with its strategic goals to enhance core competitiveness [6] - The company has outlined a clear roadmap for high-quality development during the 14th Five-Year Plan period, focusing on talent, R&D, market expansion, governance, and green development [6] - The company is committed to integrating into local industrial layouts and development plans, promoting sustainable practices through increased environmental investment and resource recycling [7]

Core Viewpoint - The article highlights how Boyuan Co., Ltd. is navigating the transformation of the chemical industry towards green and high-quality development, leveraging a circular economy model to enhance resource utilization and economic benefits while addressing environmental concerns [1]. Group 1: Circular Economy and Business Model - Boyuan Co., Ltd. has established a circular economy business model centered on the recovery and utilization of iodine and precious metals, differentiating itself from traditional chemical companies [3]. - The company effectively addresses waste disposal challenges for upstream enterprises, facilitating compliance and resource utilization, which in turn broadens its raw material sources and reduces production costs [3]. - This model not only mitigates risks associated with raw material price fluctuations but also fosters long-term partnerships with clients, enhancing operational stability and sustainability [3]. Group 2: Product and Market Position - Boyuan Co., Ltd. has developed a comprehensive service capability that spans the entire industrial chain, from basic chemical raw material supply to hazardous waste resource utilization and product processing, strengthening strategic partnerships with major clients [4]. - The company holds a leading position in the iodine resource utilization sector, thanks to its mature recovery processes and large-scale processing capabilities [4]. - In the organic iodine market, products like trimethyl iodide occupy significant market shares, while inorganic iodides such as potassium iodate and potassium iodide are widely used in critical industries like pharmaceuticals and chemicals [7]. Group 3: Technological Innovation and Development Strategy - The company emphasizes the importance of innovation as a growth engine, supported by a strong technical foundation and a competitive product matrix [7]. - Boyuan Co., Ltd. is increasing R&D investments and enhancing its innovation center to accelerate the commercialization of research outcomes and the development of new products and technologies [8]. - The company is also focusing on high-end fields such as new materials and new energy, aiming to upgrade its product offerings to higher value-added areas and cultivate new growth points [9]. Group 4: Strategic Growth and Future Outlook - Boyuan Co., Ltd. maintains a cautious yet open approach to mergers and acquisitions, considering opportunities that align with its strategic goals to enhance core competitiveness [11]. - The company has outlined a clear roadmap for high-quality development during the 14th Five-Year Plan period, focusing on talent, R&D, market expansion, governance, and green development [12]. - By integrating green, low-carbon, and sustainable practices into its operations, Boyuan Co., Ltd. aims to contribute to regional economic development while positioning itself as a benchmark for high-quality development in the fine chemical industry [12].

Market Outlook - The market for inorganic iodides is expected to grow significantly due to increasing medical expenditures driven by rising living standards, aging populations, and heightened health awareness [2][3] - The demand for contrast agents in the diagnosis of diseases such as tumors, cardiovascular diseases, and neurological disorders is projected to steadily increase, expanding the domestic contrast agent market [2][3] - The rapid development of the global pharmaceutical industry, particularly in new drug research and development, is expected to further drive the demand for high-quality pharmaceutical intermediates [3] Production Capacity Expansion - The company is establishing a new production project for 4,000 tons/year of inorganic iodides to enhance capacity and diversify its product offerings, focusing on high-value products for pharmaceutical and electronic applications [4] Competitive Advantages - **Resource Recycling and Service Integration**: The company has developed a unique "iodine resource recycling" industry chain, reducing reliance on imported iodine and lowering procurement costs while providing integrated solutions to clients [4] - **Regulatory Compliance and Scale**: As a leading iodine resource utilization enterprise, the company has a robust capacity for iodine recycling and complies with environmental regulations, enhancing collaboration with clients [4][5] - **Technological Innovation**: The company emphasizes continuous technological advancement and has established a comprehensive R&D and talent incentive system, leading to industry-leading processes and patented technologies [5] - **Quality Control and Client Relationships**: A thorough quality control system ensures product quality, with core products certified by authoritative bodies, fostering long-term trust with major clients [5] Shareholder Information - The company plans to release 19,630,000 shares from lock-up on December 11, 2025, with no current plans for shareholder reductions communicated [5]

Group 1 - The company hosted a specific research meeting with five institutions including Industrial Securities and CITIC Construction Investment on September 11 [1] - The meeting included a tour of the company's exhibition hall and an introduction to its basic situation, followed by in-depth discussions focusing on several business points [2] Group 2 - Iodine and its derivatives are important raw materials in medical, agricultural, industrial, and nutritional fields, with key applications in X-ray contrast agents, disinfectants, etc. According to SQM's 2024 report, these applications account for approximately 63% of global iodine consumption [2] - The company produces inorganic iodides such as potassium iodide and potassium iodate, which are used in pharmaceuticals and pesticides, while its organic iodide product trimethyl iodide is primarily used in the pharmaceutical sector [2] - The company has not yet achieved sales in the solid-state battery sector but plans to explore new industrial application scenarios and conduct feasibility studies [2] - The expansion into hexamethyldisilazane is driven by existing pharmaceutical customer needs and the company's advantages in resource utilization and process technology [2]

Group 1: Company Overview - The company is Shandong Boyuan Pharmaceutical Chemical Co., Ltd., with stock code 301617 and abbreviation Boyuan Shares [1]. - The investor relations activity took place on September 11, 2025, in the Boyuan Shares conference room [2]. Group 2: Key Products and Applications - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, widely used in various product formulations [2]. - The downstream application structure of iodine includes three core areas: X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing, which together account for approximately 63% of global consumption [2]. - Major iodine production is concentrated in Chile, Japan, and the USA, with these three countries expected to account for 88% of global production [3]. Group 3: Product Specifics - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide, primarily used in pharmaceuticals, pesticides, feed, and optoelectronic materials [4]. - The company’s organic iodide product, trimethylsilyl iodide, is used as a protecting group in organic synthesis, particularly in the production of antibiotics [4]. Group 4: Business Development and Future Plans - Currently, the company has not achieved sales in the solid-state battery sector but is exploring new application scenarios and conducting feasibility studies [4]. - The expansion into hexamethyldisilazane products is driven by existing pharmaceutical customer needs and the company's resource utilization capabilities [5]. - The company leverages its expertise in waste recovery to develop hexamethyldisilazane products, which share similar application scenarios and functional characteristics with iodides [5].

Group 1: Company Overview - The company is Shandong Boyuan Pharmaceutical Chemical Co., Ltd., with stock code 301617 and abbreviation Boyuan Co. [1] - The company specializes in iodine and iodine derivatives, which are essential raw materials in various fields including medicine, agriculture, and industry [2][4]. Group 2: Iodine Market Insights - Iodine and its derivatives are widely used in X-ray contrast agents, disinfectants, and LCD screen polarizers, with the three core applications accounting for approximately 63% of global consumption [2][3]. - Major iodine production is concentrated in Chile, Japan, and the United States, which together account for 88% of global sales, with Chilean companies alone contributing about 60% [2][3]. Group 3: Product Portfolio - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, and hydrogen iodide, primarily used in pharmaceuticals, pesticides, and optical materials [4]. - The company also produces trimethyl iodide silane, used as a functional group protecting agent in organic synthesis, particularly in antibiotic production [4]. Group 4: Competitive Advantages - **Circular Development and Comprehensive Service**: The company integrates resource recycling with its main business, ensuring stable supply and low costs through waste material recovery [5]. - **Research and Development Strength**: The company has a professional R&D team with over 30 years of industry experience and has obtained 51 patents as of June 30, 2025 [5]. - **Industry Position**: The company maintains a leading market position in iodides and luminescent materials, with products recognized for their quality and performance [5][6]. - **Quality Control and Customer Relationships**: A comprehensive quality control system ensures high-quality products, fostering long-term partnerships with well-known clients [6]. - **Compliance and Safety**: The company adheres to strict compliance standards, holding all necessary safety and environmental permits, which enhances customer trust [6]. Group 5: Industry Standards and Influence - The company has participated in the formulation of 3 industry standards and 12 group standards, reflecting its influence and technical authority in the industry [6].

Core Viewpoint - The company, Boyuan Co., Ltd. (301617), announced its product offerings and applications in various fields, highlighting its inorganic and organic iodides [1] Group 1: Inorganic Iodides - The company's inorganic iodides include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide [1] - These products are primarily used in pharmaceuticals, pesticides, animal feed, and optoelectronic materials [1] Group 2: Organic Iodides - The company's organic iodide product, trimethyl iodide silane, serves as a functional group protecting agent in organic synthesis [1] - This product is mainly applied in the pharmaceutical industry, particularly in the production of cephalosporins and macrolide antibiotics [1]

Group 1: Market Overview - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, with applications in X-ray contrast agents, disinfectants, and LCD/LED screens [2] - The downstream application structure of iodine includes three core areas: X-ray contrast agents, pharmaceutical manufacturing, and LCD panel manufacturing, accounting for approximately 63% of global consumption [2] - Major iodine production is concentrated in Chile, Japan, and the USA, which together account for 88% of global sales, with Chilean companies alone contributing 60% [2][3] Group 2: Product Portfolio - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, hydrogen iodide, and cuprous iodide, primarily used in pharmaceuticals, pesticides, and optoelectronic materials [4] - The organic iodide product trimethyl iodide is utilized as a protecting agent in pharmaceutical synthesis, particularly in the production of antibiotics [4] Group 3: Competitive Advantages - The company integrates resource recycling with core business, creating a circular economy model that ensures stable supply and low costs [5] - A strong R&D team with over 30 years of industry experience has led to the acquisition of 51 patents, enhancing the company’s technological capabilities [5] - The company maintains a leading market position in iodides and luminescent materials, with established long-term partnerships with renowned clients [5][6] Group 4: Quality and Compliance - A comprehensive quality control system spans procurement, production, and sales, ensuring high-quality products and stable supply [6] - The company adheres to compliance in operations, holding all necessary safety and environmental permits, which fosters customer trust and supports sustainable growth [6]

Core Viewpoint - The announcement from Boyuan Co., Ltd. highlights the company's focus on inorganic and organic iodides, emphasizing their applications in various industries such as pharmaceuticals, pesticides, animal feed, and optoelectronic materials [1] Group 1: Inorganic Iodides - The main products of the company in the inorganic iodide category include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide [1] - These inorganic iodides are primarily utilized in the pharmaceutical, pesticide, animal feed, and optoelectronic materials sectors [1] Group 2: Organic Iodides - The company's organic iodide product, trimethyl iodide silane, serves as a functional group protecting agent in organic synthesis [1] - This product is mainly applied in the pharmaceutical industry, particularly in the production of antibiotics such as cephalosporins and macrolides [1]